| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 276 | 2018 |
| CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial DM Smith, KW Weitzel, AR Elsey, T Langaee, Y Gong, DT Wake, ... Genetics in Medicine 21 (8), 1842-1850, 2019 | 141 | 2019 |
| Institutional profile: University of Florida health personalized medicine program LH Cavallari, KW Weitzel, AR Elsey, X Liu, SA Mosley, DM Smith, ... Pharmacogenomics 18 (5), 421-426, 2017 | 67 | 2017 |
| Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene–drug pairs across ambulatory care settings EJ Cicali, KW Weitzel, AR Elsey, FA Orlando, M Vinson, S Mosley, ... Genetics in Medicine 21 (10), 2264-2274, 2019 | 64 | 2019 |
| Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing LH Cavallari, SL Van Driest, CA Prows, JR Bishop, NA Limdi, VM Pratt, ... Genetics in Medicine 21 (10), 2255-2263, 2019 | 63 | 2019 |
| How to integrate CYP2D6 phenoconversion into clinical pharmacogenetics: a tutorial EJ Cicali, AL Elchynski, KJ Cook, JT Houder, CD Thomas, DM Smith, ... Clinical Pharmacology & Therapeutics 110 (3), 677-687, 2021 | 54 | 2021 |
| Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention LH Cavallari, F Franchi, F Rollini, L Been, A Rivas, M Agarwal, DM Smith, ... Journal of translational medicine 16, 1-10, 2018 | 50 | 2018 |
| PharmGKB summary: sertraline pathway, pharmacokinetics R Huddart, JK Hicks, LB Ramsey, JR Strawn, DM Smith, MB Babilonia, ... Pharmacogenetics and genomics 30 (2), 26-33, 2020 | 44 | 2020 |
| Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing JD Duarte, R Dalton, AL Elchynski, DM Smith, EJ Cicali, JC Lee, ... Genetics in Medicine 23 (12), 2335-2341, 2021 | 42 | 2021 |
| Pharmacogenomic clinical decision support: a review, how‐to guide, and future vision DT Wake, DM Smith, S Kazi, HM Dunnenberger Clinical Pharmacology & Therapeutics 112 (1), 44-57, 2022 | 39 | 2022 |
| Design and early implementation successes and challenges of a pharmacogenetics consult clinic MJ Arwood, EA Dietrich, BQ Duong, DM Smith, K Cook, A Elchynski, ... Journal of clinical medicine 9 (7), 2274, 2020 | 38 | 2020 |
| DPYD Testing: Time to Put Patient Safety First SD Baker, SE Bates, GA Brooks, WL Dahut, RB Diasio, WS El-Deiry, ... Journal of Clinical Oncology 41 (15), 2701-2705, 2023 | 36 | 2023 |
| Implementation of standardized clinical processes for TPMT testing in a diverse multidisciplinary population: challenges and lessons learned KW Weitzel, DM Smith, AR Elsey, BQ Duong, B Burkley, M Clare‐Salzler, ... Clinical and translational science 11 (2), 175-181, 2018 | 36 | 2018 |
| Clinical application of pharmacogenetics in pain management DM Smith, KW Weitzel, LH Cavallari, AR Elsey, SOF Schmidt Personalized medicine 15 (2), 117-126, 2018 | 35 | 2018 |
| Assessment of primary care practitioners’ attitudes and interest in pharmacogenomic testing DM Smith, T Namvar, RP Brown, TB Springfield, BN Peshkin, RJ Walsh, ... Pharmacogenomics 21 (15), 1085-1094, 2020 | 30 | 2020 |
| Pharmacogenetics in practice: estimating the clinical actionability of pharmacogenetic testing in perioperative and ambulatory settings DM Smith, BN Peshkin, TB Springfield, RP Brown, E Hwang, S Kmiecik, ... Clinical and translational science 13 (3), 618-627, 2020 | 26 | 2020 |
| Acceptability, feasibility, and utility of integrating pharmacogenetic testing into a child psychiatry clinic K Claudio‐Campos, A Padrón, G Jerkins, J Nainaparampil, R Nelson, ... Clinical and Translational Science 14 (2), 589-598, 2021 | 24 | 2021 |
| A scoping review of the evidence behind cytochrome P450 2D6 isoenzyme inhibitor classifications EJ Cicali, DM Smith, BQ Duong, LG Kovar, LH Cavallari, JA Johnson Clinical Pharmacology & Therapeutics 108 (1), 116-125, 2020 | 24 | 2020 |
| Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy S Tuteja, RG Salloum, AL Elchynski, DM Smith, E Rowe, KV Blake, ... Clinical and translational science 15 (2), 371-383, 2022 | 18 | 2022 |
| Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy DL Hertz, DM Smith, SA Scott, JN Patel, JK Hicks Clinical Pharmacology & Therapeutics 114 (4), 768-779, 2023 | 12 | 2023 |
Julie A JohnsonThe Ohio State University在 osumc.edu 的电子邮件经过验证
